Targeted
Medical Pharma, Inc. (OTCQB: TRGM), announced the establishment of a
new subsidiary, Amino Nutritionals LLC, that will specialize in the
development and marketing of THERALEVE™,
a proprietary consumer product for chronic pain sufferers to be sold in
the United States and abroad.
The Company is pleased to announce the hiring of Joshua Levine as the
Vice President of Direct Consumer Sales. Mr. Levine will spearhead the
direct marketing efforts for Amino Nutritionals, and will be responsible
for building the infrastructure required for market development and
growth of the new direct to consumer products. Josh was most recently
the Vice President of Finance for Ideal Living Management, LLC.
“The Company has been through a challenging year, restructuring
management and operations to improve profitability and shareholder
value. Adding Josh to our corporate team signifies our commitment to
growth,” said Kim Giffoni, CEO at Targeted Medical Pharma. “Our patented
Targeted Cellular Technology that is responsible for the efficacy and
safety of our medical
foods will give THERALEVE™ a distinct advantage in the
direct to consumer market.”
About Targeted Medical Pharma, Inc.
Targeted
Medical Pharma, Inc. (OTCQB:TRGM) is a Los Angeles based
biotechnology company that develops and manufactures amino acid based
Medical Foods featuring the patented Targeted Cellular Technology. The
Company distributes these products to physicians, pharmacies, hospitals
and patients throughout the United States, to effectively treat pain,
obesity, hypertension, sleep and cognitive disorders without the serious
side effects associated with many drug therapies.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151203005319/en/
Copyright Business Wire 2015